Effect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation
- PMID: 27423055
- PMCID: PMC8354204
- DOI: 10.1111/ctr.12811
Effect of moderately intense perioperative glucose control on renal allograft function: a pilot randomized controlled trial in renal transplantation
Abstract
Recipient diabetes accounts for ~34% of end-stage renal disease in patients awaiting renal transplantation and has been linked to poor graft function. We conducted a single-center, open-label, randomized controlled trial to determine whether moderately intense glucose control during allograft reperfusion would reduce the incidence of poor graft function. Adult diabetics undergoing deceased donor renal transplant were randomized to moderately intense glucose control (n=30) or standard control (n=30). The primary outcome was poor graft function (dialysis within seven days of transplant or failure of serum creatinine to fall by 10% for three consecutive days). Recipients with moderately intense glucose control had less poor graft function in the intention-to-treat (43.3% vs 73.3%, P=.02) and per-protocol analysis (43.2% vs 81%, P<.01). Recipients with moderately intense control also had higher glomerular filtration rate (GFR) at 30 days after transplant in the per-protocol and intention-to-treat analyses. There were no episodes of severe hypoglycemia in either group and no differences in mortality, seizures, stroke, graft loss, or biopsy-proven rejection. Moderately intense glucose control at the time of allograft reperfusion reduces the incidence of poor graft function in diabetic renal transplant recipients and improves glomerular filtration rate at 30 days.
Trial registration: ClinicalTrials.gov NCT01643382.
Keywords: delayed graft function; diabetes; hyperglycemia; kidney transplantation; poor graft function.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures


References
-
- Van den Berghe G, Schetz M, Vlasselaers D, et al.Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? The Journal of clinical endocrinology and metabolism. 2009;94(9):3163–3170. - PubMed
-
- van den Berghe G, Wouters P, Weekers F, et al.Intensive insulin therapy in critically ill patients. The New England journal of medicine. 2001;345(19):1359–1367. - PubMed
-
- Investigators N-SS, Finfer S, Chittock DR, et al.Intensive versus conventional glucose control in critically ill patients. The New England journal of medicine. 2009;360(13):1283–1297. - PubMed
-
- Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2004;10Suppl 2:21–33. - PubMed
-
- Nagamizo D, Tsuruta S, Matsumoto M, Matayoshi H, Yamashita A, Sakabe T. Tight glycemic control by insulin, started in the preischemic, but not postischemic, period, protects against ischemic spinal cord injury in rabbits. Anesthesia and analgesia. 2007;105(5):1397–1403, table of contents. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical